本页面由Tiger Trade Technology Pte. Ltd.提供服务

Rhythm Pharmaceuticals Inc.

87.38
-2.4450-2.72%
成交量:23.34万
成交额:2,055.26万
市值:60.16亿
市盈率:-28.03
高:90.51
开:89.63
低:87.20
收:89.82
52周最高:122.20
52周最低:74.50
股本:6,885.21万
流通股本:6,539.41万
量比:0.40
换手率:0.36%
股息:- -
股息率:- -
每股收益(TTM):-3.1172
每股收益(LYR):-3.1100
净资产收益率:-117.04%
总资产收益率:-30.96%
市净率:58.42
市盈率(LYR):-28.09

数据加载中...

2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

重要事件披露

Form 8-K - Current report
2024/06/17

重要事件披露

Form 8-K - Current report
2024/05/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/30

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/17

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/03

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/20

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]